Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

| More on:
Cannabis grows at a commercial farm.

Source: Getty Images

SNDL (NYSE:SNDL) is a Canada-based cannabis stock that is currently trading 94% below all-time highs. SNDL stock has burnt massive investor wealth ever since it was listed as a public company in August 2019. Valued at a market cap of $500 million, SNDL has been among the worst-performing companies in the last 12 months.

The global cannabis market is estimated to expand at a rapid pace in the upcoming decade, especially if the recreational use of marijuana is legalized at the federal level in several regions.

While SNDL is trailing the broader markets by a wide margin, let’s see if it can stage a comeback in 2023.

Is SNDL stock a buy right now?

In the last 12 months, SNDL has reported sales of $494.5 million, an increase of 700% in the last three years. Despite its enviable revenue growth, SNDL reported an operating loss of $52.3 million in the past four quarters. Its gross margin is currently less than 20%, and the company has to increase top line at a robust pace to improve profit margins further.

SNDL is Canada’s largest private-sector cannabis and liquor retailer. It has 169 retail liquor locations, most of which are in Alberta. It also operates 183 cannabis retail outlets under banners such as “Value Buds” and “Spiritleaf.”

While SNDL’s liquor sales were flat year over year in the third quarter (Q3), gross revenue from its cannabis retail segment rose to $66.2 million compared to just $6 million in the year-ago period. Sales growth in Q3 was primarily driven by the acquisition of Nova Cannabis and Value Buds, which brought in $58.9 million in revenue in this period.

Additionally, the company operates an investment portfolio where it deploys strategic capital to other cannabis operators. SNDL has deployed $677.5 million in cannabis-related investments to date. In Q3, its investment portfolio generated interest and fee revenue totaling $4.3 million, compared to $3.3 million in the year-ago period.

What’s next for SNDL stock and investors?

While SNDL is expected to report an EBITDA loss of $49 million in 2022, it’s estimated to end 2023 with an EBITDA (earnings before interest, taxes, depreciation, and amortization) profit of $57 million. Analysts tracking the company also expect its sales to rise to $510 million in 2022 and $707.2 million in 2023.

SNDL stock is valued at less than one times forward sales due to its vulnerable liquidity position. It ended Q3 with $325 million in cash, indicating the company will have to raise capital and support its cash-burn rate.

SNDL will either dilute shareholder wealth or increase balance sheet debt, which will make investors nervous. Further, the Canadian cannabis market is wrestling with a range of structural issues, including a thriving black market, rising inventory levels, goodwill write-downs, and negative profit margins.

SNDL remains focused on creating shareholder value through vertical integration, expansion of retail distribution networks, streamlining operations, and enhancing the offerings of high-quality brands. But to regain investor confidence, SNDL will have to race toward profitability and generate consistent cash flows.

Analysts tracking SNDL stock remain bullish and have a 12-month price target of $4.13, indicating an upside potential of 80%.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »